期刊
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
卷 55, 期 4-5, 页码 527-534出版社
U B C PRESS
DOI: 10.1387/ijdb.103228jl
关键词
angiogenesis; cancer; bone marrow-derived cell; myelomonocytic cell; inflammation
资金
- National Center of Competence in Research (NCCR)
- Swiss National Science Foundation
- Oncosuisse [CCRP-OCS-01812-12-2005]
- MEDIC foundation
- European Frame Program 7
- Fond'Action contre le cancer
Cancer-related inflammation has emerged in recent years as a major event contributing to tumor angiogenesis, tumor progression and metastasis formation. Bone marrow-derived and inflammatory cells promote tumor angiogenesis by providing endothelial progenitor cells that differentiate into mature endothelial cells, and by secreting pro-angiogenic factors and remodeling the extracellular matrix to stimulate angiogenesis though paracrine mechanisms. Several bone marrow-derived myelonomocytic cells, including monocytes and macrophages, have been identified and characterized by several laboratories in recent years. While the central role of these cells in promoting tumor angiogenesis, tumor progression and metastasis is nowadays well established, many questions remain open and new ones are emerging. These include the relationship between their phenotype and function, the mechanisms of pro-angiogenic programming, their contribution to resistance to anti-angiogenic treatments and to metastasis and their potential clinical use as biomarkers of angiogenesis and anti-angiogenic therapies. Here, we will review phenotypical and functional aspects of bone marrow-derived myelonomocytic cells and discuss some of the current outstanding questions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据